| Product Code: ETC9979912 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) mRNA Vaccine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) mRNA Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) mRNA Vaccine Market - Industry Life Cycle |
3.4 United States (US) mRNA Vaccine Market - Porter's Five Forces |
3.5 United States (US) mRNA Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) mRNA Vaccine Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 United States (US) mRNA Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of mRNA vaccines for infectious diseases |
4.2.2 Growing investment in research and development of mRNA vaccine technology |
4.2.3 Favorable regulatory environment for the approval and distribution of mRNA vaccines in the US |
4.3 Market Restraints |
4.3.1 Potential safety concerns and side effects associated with mRNA vaccines |
4.3.2 Supply chain constraints and logistical challenges in manufacturing and distribution |
4.3.3 Competition from traditional vaccines and other new vaccine technologies |
5 United States (US) mRNA Vaccine Market Trends |
6 United States (US) mRNA Vaccine Market, By Types |
6.1 United States (US) mRNA Vaccine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) mRNA Vaccine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) mRNA Vaccine Market Revenues & Volume, By COVID-19, 2021- 2031F |
6.1.4 United States (US) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) mRNA Vaccine Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 United States (US) mRNA Vaccine Market Revenues & Volume, By Government, 2021- 2031F |
6.2.3 United States (US) mRNA Vaccine Market Revenues & Volume, By Private Hospitals & Clinics, 2021- 2031F |
6.2.4 United States (US) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) mRNA Vaccine Market Import-Export Trade Statistics |
7.1 United States (US) mRNA Vaccine Market Export to Major Countries |
7.2 United States (US) mRNA Vaccine Market Imports from Major Countries |
8 United States (US) mRNA Vaccine Market Key Performance Indicators |
8.1 Vaccine efficacy rate in clinical trials |
8.2 Rate of vaccine adoption among targeted population groups |
8.3 Investment in mRNA vaccine research and development |
8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for mRNA vaccine development |
8.5 Regulatory approvals for new mRNA vaccines and expansion of indications |
9 United States (US) mRNA Vaccine Market - Opportunity Assessment |
9.1 United States (US) mRNA Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) mRNA Vaccine Market Opportunity Assessment, By End users, 2021 & 2031F |
10 United States (US) mRNA Vaccine Market - Competitive Landscape |
10.1 United States (US) mRNA Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) mRNA Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here